“Don’t Kill My Buzz, Man!” – Explaining the Criminalization of Psychedelic Drugs
Conrad Sproul
Oregon Undergraduate Research Journal June 1, 2021 DOI: 10.5399/uo/ourj.19.1.2 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Keywords | Criminalization Moral panic Criminology Possession linguistics Testimonial Law |
| Citations | 2 |
| Key points | Argues that psychedelic criminalization resulted from early 20th-century temperance moral frameworks and professional psychiatric rejection in the early 1960s, not solely from a moral panic. |
Abstract
In the 1950s, psychedelic drugs were the subject of extensive psychiatric research in the United States. By 1960, they had been found to be non-addictive, to have remarkable safety profiles, and to potentially be able to treat a range of psychological conditions. However, in 1968, the possession of psychedelics was criminalized by the US federal government. Consequently, medical research has been stifled, and today the possession and distribution of psychedelics are punished more severely than for more dangerous recreational drugs such as methamphetamine. Most scholars argue that psychedelics were criminalized due to a “moral panic” in the late 1960s. However, this theory overlooks several important aspects of the political process that led to psychedelic criminalization. This essay takes an alternative stance. First, early 20th century temperance advocates instilled an anti-drug moral framework into the American cultural consciousness. Then, in the early 1960s, safety concerns and professional biases led most mainstream psychiatrists to reject the therapeutic use of psychedelics. These factors interacted to cause both a moral panic and severe criminalization, but the moral panic did not itself cause criminalization.
Citations in the library
Cited by 2
- “Ontological shocks”: new transformations for sustainability through psychedelic tourism Journal of Sustainable Tourism 2026
- Field Notes From Inner Space: Global Psychedelic Survey Participants Report Health Benefits, Personal Growth, and Life Transformations Contemporary Drug Problems April 25, 2026
Cites 9
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Acta Psychiatrica Scandinavica October 30, 2020
- Psychedelics not linked to mental health problems or suicidal behavior: A population study Journal of Psychopharmacology March 1, 2015
- The Experimental Use of Psychedelic (LSD) Psychotherapy JAMA June 15, 1970
- The relationships of classic psychedelic use with criminal behavior in the United States adult population Journal of Psychopharmacology October 17, 2017
and 4 more in the library